| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Leukomalacia, Periventricular | 46 | 2023 | 184 | 5.220 |
Why?
|
| Infant, Premature | 54 | 2023 | 2124 | 3.510 |
Why?
|
| Infant, Premature, Diseases | 23 | 2020 | 712 | 3.210 |
Why?
|
| Oligodendroglia | 44 | 2011 | 540 | 2.960 |
Why?
|
| Hypoxia-Ischemia, Brain | 17 | 2023 | 359 | 1.870 |
Why?
|
| Nerve Fibers, Myelinated | 18 | 2021 | 953 | 1.770 |
Why?
|
| Developmental Disabilities | 11 | 2021 | 1516 | 1.480 |
Why?
|
| Brain Injuries | 12 | 2022 | 2059 | 1.350 |
Why?
|
| Infant, Newborn | 119 | 2023 | 26411 | 1.260 |
Why?
|
| Brain | 59 | 2023 | 27454 | 1.040 |
Why?
|
| Brain Diseases | 10 | 2019 | 1552 | 0.940 |
Why?
|
| Cerebral Hemorrhage | 25 | 2022 | 2653 | 0.930 |
Why?
|
| Infant, Newborn, Diseases | 7 | 2021 | 591 | 0.920 |
Why?
|
| Infant, Very Low Birth Weight | 10 | 2005 | 408 | 0.920 |
Why?
|
| Cerebral Cortex | 25 | 2012 | 5831 | 0.820 |
Why?
|
| Cerebral Ventricles | 10 | 2020 | 550 | 0.680 |
Why?
|
| Neuroprotective Agents | 8 | 2019 | 957 | 0.640 |
Why?
|
| Nerve Degeneration | 4 | 2021 | 750 | 0.620 |
Why?
|
| Trace Elements | 1 | 2019 | 193 | 0.570 |
Why?
|
| Marijuana Smoking | 1 | 2020 | 259 | 0.530 |
Why?
|
| Zinc | 2 | 2019 | 677 | 0.520 |
Why?
|
| Premature Birth | 4 | 2023 | 1814 | 0.500 |
Why?
|
| Erythropoietin | 1 | 2020 | 719 | 0.490 |
Why?
|
| Nerve Regeneration | 2 | 2019 | 799 | 0.480 |
Why?
|
| Magnetic Resonance Imaging | 37 | 2023 | 36849 | 0.470 |
Why?
|
| Vitamin K Deficiency Bleeding | 1 | 2014 | 9 | 0.470 |
Why?
|
| Neurology | 2 | 2014 | 786 | 0.460 |
Why?
|
| Vitamin K Deficiency | 1 | 2014 | 24 | 0.460 |
Why?
|
| Leukoencephalopathies | 1 | 2017 | 260 | 0.450 |
Why?
|
| Cannabis | 1 | 2020 | 445 | 0.430 |
Why?
|
| Cell Death | 18 | 2009 | 1682 | 0.430 |
Why?
|
| Hypothermia, Induced | 4 | 2023 | 756 | 0.430 |
Why?
|
| Infant Behavior | 1 | 2014 | 157 | 0.420 |
Why?
|
| Cerebral Infarction | 11 | 2007 | 975 | 0.410 |
Why?
|
| Neonatology | 1 | 2014 | 141 | 0.400 |
Why?
|
| Hypoxia, Brain | 6 | 2013 | 139 | 0.390 |
Why?
|
| Animals, Newborn | 23 | 2011 | 2695 | 0.380 |
Why?
|
| Glutathione | 6 | 2004 | 585 | 0.370 |
Why?
|
| Terminology as Topic | 2 | 2017 | 1539 | 0.370 |
Why?
|
| Telencephalon | 4 | 2007 | 142 | 0.360 |
Why?
|
| Treatment Refusal | 1 | 2014 | 432 | 0.360 |
Why?
|
| Brain Damage, Chronic | 4 | 2007 | 267 | 0.350 |
Why?
|
| Neurons | 18 | 2012 | 9513 | 0.350 |
Why?
|
| Iron | 1 | 2019 | 1814 | 0.340 |
Why?
|
| Cerebellum | 8 | 2009 | 1514 | 0.340 |
Why?
|
| Cognition Disorders | 5 | 2021 | 3985 | 0.330 |
Why?
|
| Neurologic Examination | 9 | 2023 | 916 | 0.330 |
Why?
|
| Oxidative Stress | 13 | 2009 | 3139 | 0.330 |
Why?
|
| Pregnancy Complications | 4 | 2020 | 2972 | 0.320 |
Why?
|
| Parechovirus | 1 | 2008 | 4 | 0.320 |
Why?
|
| Excitatory Amino Acid Transporter 2 | 4 | 2012 | 89 | 0.310 |
Why?
|
| Astrocytes | 13 | 2012 | 1349 | 0.310 |
Why?
|
| Receptors, Glutamate | 4 | 2004 | 229 | 0.300 |
Why?
|
| Encephalitis, Viral | 1 | 2008 | 59 | 0.300 |
Why?
|
| Echoencephalography | 3 | 2004 | 134 | 0.300 |
Why?
|
| Fetal Diseases | 3 | 2008 | 916 | 0.300 |
Why?
|
| Cerebrovascular Circulation | 7 | 2022 | 2736 | 0.300 |
Why?
|
| Gestational Age | 19 | 2023 | 3615 | 0.290 |
Why?
|
| Microglia | 9 | 2011 | 1374 | 0.280 |
Why?
|
| Spectroscopy, Near-Infrared | 4 | 2004 | 752 | 0.280 |
Why?
|
| Electroencephalography | 7 | 2023 | 6317 | 0.280 |
Why?
|
| Lipid Peroxidation | 4 | 2006 | 276 | 0.270 |
Why?
|
| Humans | 142 | 2023 | 768393 | 0.270 |
Why?
|
| Fetus | 16 | 2012 | 1883 | 0.270 |
Why?
|
| Receptors, AMPA | 7 | 2011 | 335 | 0.270 |
Why?
|
| Meningitis, Bacterial | 2 | 2002 | 225 | 0.250 |
Why?
|
| Interleukin-1beta | 1 | 2011 | 1020 | 0.250 |
Why?
|
| Awards and Prizes | 1 | 2010 | 365 | 0.250 |
Why?
|
| Free Radicals | 8 | 2005 | 238 | 0.250 |
Why?
|
| Rats | 40 | 2011 | 23835 | 0.250 |
Why?
|
| Rats, Sprague-Dawley | 25 | 2011 | 8199 | 0.250 |
Why?
|
| Glutamic Acid | 7 | 2011 | 1193 | 0.240 |
Why?
|
| Myelin Sheath | 7 | 2008 | 653 | 0.240 |
Why?
|
| Kainic Acid | 3 | 2009 | 203 | 0.240 |
Why?
|
| Oxygen | 8 | 2022 | 4273 | 0.240 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2008 | 327 | 0.230 |
Why?
|
| Excitatory Amino Acid Agonists | 3 | 2004 | 142 | 0.230 |
Why?
|
| Infant | 34 | 2023 | 36510 | 0.230 |
Why?
|
| Asphyxia Neonatorum | 2 | 2004 | 111 | 0.220 |
Why?
|
| Glucocorticoids | 2 | 2005 | 2168 | 0.220 |
Why?
|
| Cell Count | 10 | 2012 | 1833 | 0.210 |
Why?
|
| Excitatory Amino Acid Antagonists | 8 | 2011 | 452 | 0.210 |
Why?
|
| Apoptosis | 13 | 2011 | 9516 | 0.210 |
Why?
|
| Cystine | 4 | 2003 | 93 | 0.210 |
Why?
|
| Seizures | 8 | 2023 | 3000 | 0.200 |
Why?
|
| Axons | 8 | 2010 | 1678 | 0.200 |
Why?
|
| Free Radical Scavengers | 3 | 1998 | 213 | 0.190 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 3 | 2013 | 905 | 0.190 |
Why?
|
| Pregnancy | 17 | 2020 | 30200 | 0.190 |
Why?
|
| Inflammation | 3 | 2011 | 10863 | 0.180 |
Why?
|
| Heart Defects, Congenital | 2 | 2014 | 4713 | 0.180 |
Why?
|
| Cerebral Veins | 2 | 2017 | 158 | 0.170 |
Why?
|
| Books | 1 | 2020 | 23 | 0.170 |
Why?
|
| Hydrocephalus | 3 | 2004 | 770 | 0.170 |
Why?
|
| Xanthenes | 1 | 1999 | 71 | 0.170 |
Why?
|
| Animals | 60 | 2019 | 169337 | 0.170 |
Why?
|
| Nitroso Compounds | 1 | 1999 | 71 | 0.170 |
Why?
|
| Brain Ischemia | 4 | 2003 | 3008 | 0.160 |
Why?
|
| Cells, Cultured | 22 | 2009 | 19022 | 0.160 |
Why?
|
| Memantine | 2 | 2011 | 111 | 0.160 |
Why?
|
| Female | 60 | 2023 | 397089 | 0.150 |
Why?
|
| Brain Edema | 2 | 1993 | 607 | 0.150 |
Why?
|
| Hypotension | 2 | 2007 | 889 | 0.150 |
Why?
|
| Peroxynitrous Acid | 3 | 2008 | 40 | 0.150 |
Why?
|
| Prosencephalon | 4 | 2006 | 306 | 0.150 |
Why?
|
| Nervous System Malformations | 1 | 2000 | 244 | 0.150 |
Why?
|
| Streptococcus agalactiae | 2 | 2006 | 338 | 0.150 |
Why?
|
| Dexamethasone | 2 | 2005 | 1965 | 0.140 |
Why?
|
| Neurosciences | 1 | 2002 | 385 | 0.140 |
Why?
|
| Oxazines | 1 | 1999 | 357 | 0.140 |
Why?
|
| Spinal Cord | 4 | 2003 | 1813 | 0.140 |
Why?
|
| Reactive Oxygen Species | 6 | 2011 | 2146 | 0.140 |
Why?
|
| Diffuse Axonal Injury | 2 | 2008 | 49 | 0.140 |
Why?
|
| Sepsis | 2 | 2008 | 2601 | 0.130 |
Why?
|
| Hemoglobins | 5 | 2000 | 1532 | 0.130 |
Why?
|
| Superoxide Dismutase | 3 | 2004 | 595 | 0.130 |
Why?
|
| Image Enhancement | 3 | 2004 | 2894 | 0.130 |
Why?
|
| Toll-Like Receptors | 3 | 2008 | 582 | 0.130 |
Why?
|
| Nerve Fibers | 2 | 2002 | 709 | 0.130 |
Why?
|
| Rats, Long-Evans | 7 | 2011 | 380 | 0.130 |
Why?
|
| Cytokines | 2 | 2008 | 7445 | 0.120 |
Why?
|
| Hyperoxia | 2 | 2008 | 261 | 0.120 |
Why?
|
| Immunohistochemistry | 16 | 2012 | 11120 | 0.120 |
Why?
|
| Catalase | 4 | 2004 | 215 | 0.120 |
Why?
|
| Cerebral Palsy | 3 | 2004 | 479 | 0.120 |
Why?
|
| Arachidonate 12-Lipoxygenase | 2 | 2006 | 82 | 0.120 |
Why?
|
| Nitric Oxide | 2 | 2004 | 2144 | 0.120 |
Why?
|
| Culture Media | 3 | 1996 | 898 | 0.120 |
Why?
|
| Pediatrics | 1 | 2010 | 3624 | 0.120 |
Why?
|
| Neurogenesis | 2 | 2019 | 864 | 0.120 |
Why?
|
| Cell Survival | 9 | 2009 | 5792 | 0.120 |
Why?
|
| Diffusion | 3 | 2003 | 818 | 0.120 |
Why?
|
| Encephalocele | 2 | 1993 | 137 | 0.110 |
Why?
|
| Male | 47 | 2023 | 364902 | 0.110 |
Why?
|
| Oxygen Consumption | 2 | 2004 | 1882 | 0.110 |
Why?
|
| Cerebrospinal Fluid | 3 | 2004 | 545 | 0.110 |
Why?
|
| Heart Arrest | 2 | 2001 | 1516 | 0.110 |
Why?
|
| Gene Expression Regulation, Developmental | 8 | 2009 | 3612 | 0.110 |
Why?
|
| Oxyhemoglobins | 3 | 2000 | 213 | 0.110 |
Why?
|
| Reference Values | 5 | 2005 | 4941 | 0.110 |
Why?
|
| Indomethacin | 1 | 1994 | 323 | 0.110 |
Why?
|
| Spectrophotometry, Infrared | 4 | 1998 | 117 | 0.110 |
Why?
|
| Central Nervous System Diseases | 1 | 1998 | 523 | 0.110 |
Why?
|
| Neurons, Afferent | 1 | 1996 | 498 | 0.110 |
Why?
|
| Blood Pressure | 5 | 2007 | 8541 | 0.100 |
Why?
|
| Intensive Care, Neonatal | 2 | 2006 | 200 | 0.100 |
Why?
|
| Excitatory Amino Acid Transporter 3 | 2 | 2009 | 32 | 0.100 |
Why?
|
| Deglutition Disorders | 1 | 1998 | 641 | 0.100 |
Why?
|
| Culture Techniques | 2 | 1995 | 530 | 0.100 |
Why?
|
| Indolizines | 1 | 1992 | 30 | 0.100 |
Why?
|
| Blood Physiological Phenomena | 1 | 1992 | 53 | 0.100 |
Why?
|
| Hepatic Encephalopathy | 1 | 1993 | 144 | 0.100 |
Why?
|
| Glutamates | 1 | 1993 | 385 | 0.100 |
Why?
|
| History, 21st Century | 2 | 2015 | 1575 | 0.100 |
Why?
|
| Academic Medical Centers | 1 | 2002 | 2783 | 0.100 |
Why?
|
| Cell Extracts | 1 | 1992 | 135 | 0.100 |
Why?
|
| Nerve Tissue | 1 | 2011 | 78 | 0.090 |
Why?
|
| Hemorrhage | 2 | 2019 | 3461 | 0.090 |
Why?
|
| Down-Regulation | 4 | 2007 | 2940 | 0.090 |
Why?
|
| Cerebrovascular Disorders | 2 | 2007 | 1486 | 0.090 |
Why?
|
| Neurosurgery | 1 | 1998 | 690 | 0.090 |
Why?
|
| Estradiol | 2 | 2009 | 1952 | 0.090 |
Why?
|
| Case-Control Studies | 8 | 2019 | 22296 | 0.090 |
Why?
|
| Disease Models, Animal | 6 | 2012 | 18362 | 0.090 |
Why?
|
| Glutamate Decarboxylase | 1 | 2011 | 239 | 0.090 |
Why?
|
| Lung Diseases | 1 | 2001 | 1925 | 0.090 |
Why?
|
| Nerve Tissue Proteins | 7 | 2011 | 4414 | 0.090 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 4 | 2023 | 2820 | 0.090 |
Why?
|
| History, 20th Century | 2 | 2015 | 2771 | 0.080 |
Why?
|
| Basal Ganglia | 3 | 2003 | 555 | 0.080 |
Why?
|
| Quinoxalines | 4 | 2009 | 297 | 0.080 |
Why?
|
| Receptors, GABA | 1 | 2011 | 313 | 0.080 |
Why?
|
| Placenta | 1 | 2019 | 1723 | 0.080 |
Why?
|
| Fetal Growth Retardation | 2 | 2005 | 591 | 0.080 |
Why?
|
| Thalamus | 4 | 2008 | 1050 | 0.080 |
Why?
|
| Magnetic Resonance Angiography | 4 | 2017 | 1434 | 0.080 |
Why?
|
| Lipopolysaccharides | 4 | 2008 | 2215 | 0.080 |
Why?
|
| Reperfusion Injury | 3 | 2005 | 1033 | 0.080 |
Why?
|
| Time Factors | 12 | 2015 | 40272 | 0.080 |
Why?
|
| Thalamic Nuclei | 1 | 2009 | 111 | 0.080 |
Why?
|
| Electron Transport Complex IV | 3 | 2004 | 192 | 0.080 |
Why?
|
| Stem Cells | 8 | 2011 | 3539 | 0.080 |
Why?
|
| Wallerian Degeneration | 1 | 2008 | 68 | 0.080 |
Why?
|
| Cell Lineage | 2 | 2011 | 2574 | 0.080 |
Why?
|
| Autopsy | 4 | 2015 | 1013 | 0.070 |
Why?
|
| Growth Cones | 1 | 2008 | 117 | 0.070 |
Why?
|
| Tegmentum Mesencephali | 1 | 2008 | 59 | 0.070 |
Why?
|
| Immunity, Innate | 4 | 2011 | 3078 | 0.070 |
Why?
|
| Infant, Extremely Low Birth Weight | 1 | 2008 | 84 | 0.070 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2009 | 515 | 0.070 |
Why?
|
| Hepatitis B | 1 | 1993 | 708 | 0.070 |
Why?
|
| Cell Differentiation | 8 | 2008 | 11668 | 0.070 |
Why?
|
| Streptococcal Infections | 1 | 1992 | 619 | 0.070 |
Why?
|
| Pyramidal Cells | 1 | 2010 | 367 | 0.070 |
Why?
|
| gamma-Aminobutyric Acid | 2 | 2011 | 1143 | 0.070 |
Why?
|
| Toll-Like Receptor 3 | 1 | 2007 | 99 | 0.070 |
Why?
|
| Infant, Low Birth Weight | 3 | 2006 | 875 | 0.070 |
Why?
|
| Cocaine | 1 | 1992 | 960 | 0.070 |
Why?
|
| Blood Flow Velocity | 3 | 2000 | 1376 | 0.070 |
Why?
|
| Glial Fibrillary Acidic Protein | 4 | 2012 | 559 | 0.070 |
Why?
|
| Cerebrum | 1 | 2008 | 132 | 0.070 |
Why?
|
| Reactive Nitrogen Species | 2 | 2003 | 35 | 0.070 |
Why?
|
| Minocycline | 1 | 2008 | 170 | 0.070 |
Why?
|
| Biomedical Research | 1 | 2002 | 3464 | 0.070 |
Why?
|
| Growth Inhibitors | 1 | 2007 | 375 | 0.070 |
Why?
|
| Glutathione Peroxidase | 2 | 2004 | 259 | 0.060 |
Why?
|
| alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 2 | 2003 | 70 | 0.060 |
Why?
|
| Toll-Like Receptor 8 | 1 | 2006 | 98 | 0.060 |
Why?
|
| Cell Division | 4 | 2004 | 4479 | 0.060 |
Why?
|
| Iatrogenic Disease | 2 | 2003 | 552 | 0.060 |
Why?
|
| Neuroglia | 3 | 2012 | 960 | 0.060 |
Why?
|
| Cysteine | 3 | 2004 | 895 | 0.060 |
Why?
|
| Glucose | 6 | 2006 | 4352 | 0.060 |
Why?
|
| Meningitis, Escherichia coli | 1 | 2004 | 2 | 0.060 |
Why?
|
| In Situ Nick-End Labeling | 4 | 2011 | 612 | 0.060 |
Why?
|
| Platelet-Derived Growth Factor | 2 | 2009 | 617 | 0.060 |
Why?
|
| Flavoproteins | 1 | 2004 | 40 | 0.060 |
Why?
|
| Drug Interactions | 3 | 2006 | 1420 | 0.060 |
Why?
|
| Neurites | 1 | 2006 | 390 | 0.060 |
Why?
|
| Infant Mortality | 2 | 2015 | 757 | 0.060 |
Why?
|
| Encephalitis | 1 | 2008 | 441 | 0.060 |
Why?
|
| Parietal Lobe | 2 | 2006 | 866 | 0.060 |
Why?
|
| Temporal Lobe | 1 | 1992 | 1728 | 0.060 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2006 | 348 | 0.060 |
Why?
|
| Demyelinating Diseases | 2 | 2008 | 358 | 0.060 |
Why?
|
| Glycoproteins | 1 | 1992 | 2204 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 7 | 2006 | 10776 | 0.060 |
Why?
|
| Analysis of Variance | 5 | 2017 | 6241 | 0.060 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2006 | 501 | 0.060 |
Why?
|
| Nitrates | 1 | 2005 | 260 | 0.060 |
Why?
|
| Incontinentia Pigmenti | 1 | 2003 | 12 | 0.060 |
Why?
|
| Fructose | 2 | 2004 | 284 | 0.060 |
Why?
|
| Dilatation, Pathologic | 2 | 2002 | 527 | 0.060 |
Why?
|
| Protein Processing, Post-Translational | 1 | 1992 | 1967 | 0.060 |
Why?
|
| Neural Inhibition | 1 | 2007 | 588 | 0.060 |
Why?
|
| Up-Regulation | 3 | 2008 | 4142 | 0.050 |
Why?
|
| Hydrogen Peroxide | 2 | 2004 | 742 | 0.050 |
Why?
|
| Vitamin K 2 | 1 | 2003 | 47 | 0.050 |
Why?
|
| Gliosis | 3 | 2010 | 246 | 0.050 |
Why?
|
| Mitochondria | 3 | 2006 | 3675 | 0.050 |
Why?
|
| Cerebellar Diseases | 1 | 2005 | 221 | 0.050 |
Why?
|
| Vitamin K 1 | 1 | 2003 | 47 | 0.050 |
Why?
|
| 6-Cyano-7-nitroquinoxaline-2,3-dione | 1 | 2003 | 55 | 0.050 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2006 | 615 | 0.050 |
Why?
|
| Neonatal Screening | 1 | 2008 | 618 | 0.050 |
Why?
|
| Blotting, Western | 5 | 2012 | 5037 | 0.050 |
Why?
|
| Receptors, Kainic Acid | 1 | 2003 | 91 | 0.050 |
Why?
|
| Boston | 3 | 2015 | 9371 | 0.050 |
Why?
|
| Skull | 1 | 2007 | 831 | 0.050 |
Why?
|
| Bystander Effect | 1 | 2003 | 89 | 0.050 |
Why?
|
| Arachidonic Acid | 1 | 2004 | 429 | 0.050 |
Why?
|
| Predictive Value of Tests | 6 | 2008 | 15455 | 0.050 |
Why?
|
| Hydrocortisone | 3 | 2005 | 1841 | 0.050 |
Why?
|
| Ciliary Neurotrophic Factor | 1 | 2003 | 77 | 0.050 |
Why?
|
| Child Behavior Disorders | 1 | 2007 | 813 | 0.050 |
Why?
|
| Receptors, Metabotropic Glutamate | 1 | 2004 | 196 | 0.050 |
Why?
|
| Cyclic AMP | 1 | 2006 | 1468 | 0.050 |
Why?
|
| Nitric Oxide Synthase | 1 | 2005 | 911 | 0.050 |
Why?
|
| Liver | 9 | 1974 | 7574 | 0.050 |
Why?
|
| Body Water | 1 | 2003 | 340 | 0.050 |
Why?
|
| Swine | 4 | 2000 | 5994 | 0.050 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 3 | 2008 | 283 | 0.050 |
Why?
|
| O Antigens | 3 | 2009 | 196 | 0.050 |
Why?
|
| Remission, Spontaneous | 2 | 2002 | 385 | 0.050 |
Why?
|
| New Zealand | 1 | 2002 | 360 | 0.050 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2003 | 216 | 0.050 |
Why?
|
| Fibroblast Growth Factors | 2 | 2009 | 873 | 0.050 |
Why?
|
| Image Processing, Computer-Assisted | 5 | 2019 | 9063 | 0.050 |
Why?
|
| Microtubule-Associated Proteins | 3 | 2012 | 1078 | 0.050 |
Why?
|
| Critical Illness | 2 | 2007 | 2755 | 0.050 |
Why?
|
| Evoked Potentials, Visual | 1 | 2004 | 420 | 0.050 |
Why?
|
| Regression Analysis | 2 | 2002 | 6350 | 0.050 |
Why?
|
| Cell Communication | 1 | 2008 | 1660 | 0.050 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 2 | 2002 | 279 | 0.050 |
Why?
|
| Rats, Wistar | 3 | 2011 | 1890 | 0.040 |
Why?
|
| Actins | 1 | 2008 | 2059 | 0.040 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 2 | 2000 | 239 | 0.040 |
Why?
|
| Cardiopulmonary Bypass | 2 | 1996 | 1097 | 0.040 |
Why?
|
| Ganglia, Spinal | 1 | 2003 | 530 | 0.040 |
Why?
|
| Regional Blood Flow | 2 | 2001 | 1502 | 0.040 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 2003 | 2185 | 0.040 |
Why?
|
| Sensitivity and Specificity | 4 | 2007 | 14737 | 0.040 |
Why?
|
| Child, Preschool | 11 | 2013 | 42650 | 0.040 |
Why?
|
| RNA, Viral | 1 | 2008 | 2866 | 0.040 |
Why?
|
| S-Nitrosoglutathione | 1 | 1999 | 23 | 0.040 |
Why?
|
| Electrophysiology | 1 | 2003 | 1266 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 3 | 2021 | 2488 | 0.040 |
Why?
|
| Pneumothorax | 1 | 2003 | 393 | 0.040 |
Why?
|
| Retrospective Studies | 10 | 2023 | 81801 | 0.040 |
Why?
|
| Prognosis | 8 | 2008 | 30022 | 0.040 |
Why?
|
| Vimentin | 2 | 2012 | 257 | 0.040 |
Why?
|
| Immunoblotting | 1 | 2003 | 1647 | 0.040 |
Why?
|
| Visual Pathways | 1 | 2004 | 559 | 0.040 |
Why?
|
| Nitrogen Oxides | 1 | 1999 | 129 | 0.040 |
Why?
|
| Intracranial Hemorrhages | 1 | 2005 | 811 | 0.040 |
Why?
|
| Nitric Oxide Donors | 1 | 1999 | 126 | 0.040 |
Why?
|
| Central Nervous System | 2 | 2007 | 1346 | 0.040 |
Why?
|
| Oxidation-Reduction | 3 | 2003 | 2225 | 0.040 |
Why?
|
| Isotope Labeling | 1 | 2000 | 395 | 0.040 |
Why?
|
| Interferon-gamma | 2 | 2004 | 3164 | 0.040 |
Why?
|
| Age Factors | 8 | 2012 | 18471 | 0.040 |
Why?
|
| Embryonic and Fetal Development | 1 | 2000 | 420 | 0.040 |
Why?
|
| Buthionine Sulfoximine | 1 | 1998 | 17 | 0.040 |
Why?
|
| Cisapride | 1 | 1998 | 22 | 0.040 |
Why?
|
| Ranitidine | 1 | 1998 | 34 | 0.040 |
Why?
|
| Prospective Studies | 6 | 2007 | 54920 | 0.040 |
Why?
|
| Dilatation | 1 | 2020 | 313 | 0.040 |
Why?
|
| Homeostasis | 2 | 2007 | 3349 | 0.040 |
Why?
|
| Mutagens | 1 | 1999 | 181 | 0.040 |
Why?
|
| Guanylate Cyclase | 1 | 1999 | 206 | 0.040 |
Why?
|
| Intracranial Arteriovenous Malformations | 1 | 2002 | 366 | 0.040 |
Why?
|
| Necrosis | 3 | 2009 | 1621 | 0.040 |
Why?
|
| Autistic Disorder | 1 | 2008 | 1240 | 0.040 |
Why?
|
| Ultrasonography | 5 | 2007 | 6001 | 0.040 |
Why?
|
| Intracranial Pressure | 1 | 2000 | 325 | 0.040 |
Why?
|
| Pharyngeal Muscles | 1 | 1998 | 81 | 0.040 |
Why?
|
| Palate, Soft | 1 | 1998 | 100 | 0.040 |
Why?
|
| Diagnostic Imaging | 1 | 2012 | 3541 | 0.040 |
Why?
|
| Malondialdehyde | 2 | 2009 | 113 | 0.040 |
Why?
|
| Growth | 1 | 2000 | 366 | 0.040 |
Why?
|
| Anatomy, Regional | 1 | 2017 | 4 | 0.040 |
Why?
|
| Tocolytic Agents | 1 | 1997 | 24 | 0.040 |
Why?
|
| Hydrazines | 1 | 1999 | 223 | 0.040 |
Why?
|
| Carbon Dioxide | 1 | 2002 | 1149 | 0.040 |
Why?
|
| Calcium | 4 | 2006 | 5794 | 0.040 |
Why?
|
| Magnesium Sulfate | 1 | 1997 | 73 | 0.040 |
Why?
|
| Microspheres | 1 | 2000 | 789 | 0.040 |
Why?
|
| Membrane Proteins | 4 | 2011 | 7880 | 0.040 |
Why?
|
| Plant Lectins | 2 | 2008 | 103 | 0.030 |
Why?
|
| Neurodegenerative Diseases | 1 | 2006 | 1094 | 0.030 |
Why?
|
| Resuscitation | 1 | 2001 | 679 | 0.030 |
Why?
|
| Coloring Agents | 1 | 1999 | 564 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2001 | 1837 | 0.030 |
Why?
|
| Models, Animal | 1 | 2003 | 2124 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2008 | 4357 | 0.030 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 1997 | 324 | 0.030 |
Why?
|
| Child Development | 2 | 2006 | 2334 | 0.030 |
Why?
|
| Interdisciplinary Communication | 1 | 2002 | 937 | 0.030 |
Why?
|
| Brain Stem | 1 | 2001 | 862 | 0.030 |
Why?
|
| Tritium | 3 | 2009 | 707 | 0.030 |
Why?
|
| Growth Substances | 1 | 1998 | 761 | 0.030 |
Why?
|
| Cerebral Arteries | 1 | 1998 | 489 | 0.030 |
Why?
|
| Portal System | 1 | 1996 | 49 | 0.030 |
Why?
|
| Dipyridamole | 1 | 1996 | 143 | 0.030 |
Why?
|
| Phlebography | 1 | 2017 | 326 | 0.030 |
Why?
|
| Maternal Age | 1 | 2019 | 809 | 0.030 |
Why?
|
| Visual Cortex | 1 | 2004 | 1112 | 0.030 |
Why?
|
| Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone | 2 | 2006 | 20 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2006 | 2911 | 0.030 |
Why?
|
| Birth Weight | 4 | 2007 | 2114 | 0.030 |
Why?
|
| Gene Expression | 1 | 2008 | 7598 | 0.030 |
Why?
|
| Signal Transduction | 5 | 2008 | 23631 | 0.030 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2003 | 1496 | 0.030 |
Why?
|
| Protein Subunits | 2 | 2011 | 943 | 0.030 |
Why?
|
| Child | 6 | 2013 | 80891 | 0.030 |
Why?
|
| Ionophores | 2 | 2006 | 108 | 0.030 |
Why?
|
| Logistic Models | 3 | 2008 | 13323 | 0.030 |
Why?
|
| Enzyme Activation | 4 | 2007 | 3587 | 0.030 |
Why?
|
| Cell Culture Techniques | 1 | 2003 | 1667 | 0.030 |
Why?
|
| Caspase 3 | 2 | 2008 | 731 | 0.030 |
Why?
|
| Diagnosis, Differential | 2 | 2008 | 13020 | 0.030 |
Why?
|
| Severity of Illness Index | 4 | 2023 | 15939 | 0.030 |
Why?
|
| Perinatal Mortality | 1 | 2015 | 102 | 0.030 |
Why?
|
| Carbocyanines | 2 | 2006 | 175 | 0.030 |
Why?
|
| Anisotropy | 1 | 1998 | 1296 | 0.030 |
Why?
|
| Parity | 1 | 1998 | 938 | 0.030 |
Why?
|
| Hexoses | 1 | 1974 | 29 | 0.030 |
Why?
|
| Aldehydes | 2 | 2006 | 170 | 0.030 |
Why?
|
| Medical Errors | 1 | 2003 | 1263 | 0.030 |
Why?
|
| Fetal Blood | 1 | 2021 | 1361 | 0.030 |
Why?
|
| Pantothenic Acid | 1 | 1973 | 17 | 0.030 |
Why?
|
| Nervous System | 3 | 1992 | 547 | 0.030 |
Why?
|
| Cell Movement | 2 | 2011 | 5215 | 0.030 |
Why?
|
| Survival Analysis | 2 | 2008 | 10117 | 0.030 |
Why?
|
| Feasibility Studies | 2 | 2005 | 5313 | 0.030 |
Why?
|
| Hyperglycemia | 1 | 2003 | 1389 | 0.030 |
Why?
|
| Risk Factors | 8 | 2015 | 74962 | 0.030 |
Why?
|
| Chick Embryo | 2 | 2007 | 975 | 0.030 |
Why?
|
| Parenteral Nutrition | 1 | 1998 | 663 | 0.030 |
Why?
|
| Mice, Inbred C3H | 2 | 2006 | 915 | 0.030 |
Why?
|
| Multivariate Analysis | 2 | 2008 | 12092 | 0.030 |
Why?
|
| Spinal Cord Injuries | 1 | 2001 | 929 | 0.030 |
Why?
|
| Bicarbonates | 1 | 1974 | 292 | 0.030 |
Why?
|
| Incidence | 4 | 2015 | 21544 | 0.030 |
Why?
|
| Electromyography | 1 | 1998 | 1402 | 0.030 |
Why?
|
| Transferases | 2 | 1970 | 71 | 0.030 |
Why?
|
| Portal Vein | 1 | 1996 | 432 | 0.030 |
Why?
|
| Superinfection | 1 | 1993 | 63 | 0.030 |
Why?
|
| Blood Coagulation | 1 | 2019 | 1161 | 0.030 |
Why?
|
| Nervous System Diseases | 2 | 1995 | 1664 | 0.030 |
Why?
|
| United States | 2 | 2020 | 73150 | 0.030 |
Why?
|
| Antigens, CD | 3 | 2008 | 4031 | 0.030 |
Why?
|
| Drosophila Proteins | 1 | 2002 | 1712 | 0.030 |
Why?
|
| Receptors, Cell Surface | 1 | 2002 | 2819 | 0.030 |
Why?
|
| L-Serine Dehydratase | 1 | 1972 | 7 | 0.030 |
Why?
|
| Artifacts | 1 | 2001 | 1930 | 0.030 |
Why?
|
| Blood Transfusion | 1 | 2019 | 1309 | 0.020 |
Why?
|
| Ventriculoperitoneal Shunt | 2 | 2007 | 187 | 0.020 |
Why?
|
| Coculture Techniques | 2 | 2008 | 1342 | 0.020 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2019 | 862 | 0.020 |
Why?
|
| alpha-Glucosidases | 1 | 1992 | 46 | 0.020 |
Why?
|
| Muscle Tonus | 1 | 1972 | 82 | 0.020 |
Why?
|
| Antioxidants | 3 | 2004 | 1673 | 0.020 |
Why?
|
| Adipose Tissue | 2 | 1974 | 3334 | 0.020 |
Why?
|
| Reflex | 1 | 1973 | 375 | 0.020 |
Why?
|
| Vasodilator Agents | 1 | 1996 | 990 | 0.020 |
Why?
|
| Carbohydrate Sequence | 1 | 1992 | 411 | 0.020 |
Why?
|
| Liver Function Tests | 1 | 1993 | 526 | 0.020 |
Why?
|
| Synapsins | 1 | 2011 | 43 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2001 | 3781 | 0.020 |
Why?
|
| Membrane Glycoproteins | 1 | 2002 | 3712 | 0.020 |
Why?
|
| Follow-Up Studies | 5 | 2007 | 39407 | 0.020 |
Why?
|
| Dizocilpine Maleate | 1 | 2011 | 173 | 0.020 |
Why?
|
| Causality | 1 | 2017 | 1255 | 0.020 |
Why?
|
| Autoradiography | 1 | 2011 | 732 | 0.020 |
Why?
|
| Microinjections | 2 | 2002 | 323 | 0.020 |
Why?
|
| D-Amino-Acid Oxidase | 1 | 1970 | 26 | 0.020 |
Why?
|
| Weight Gain | 1 | 2001 | 2356 | 0.020 |
Why?
|
| Hormones | 2 | 1972 | 870 | 0.020 |
Why?
|
| Neurofilament Proteins | 1 | 2012 | 337 | 0.020 |
Why?
|
| Acetylcholinesterase | 1 | 1970 | 151 | 0.020 |
Why?
|
| Triiodothyronine | 1 | 1972 | 492 | 0.020 |
Why?
|
| Globus Pallidus | 2 | 2007 | 250 | 0.020 |
Why?
|
| Hydro-Lyases | 1 | 1970 | 94 | 0.020 |
Why?
|
| Longitudinal Studies | 2 | 2003 | 14784 | 0.020 |
Why?
|
| Benzimidazoles | 2 | 2006 | 864 | 0.020 |
Why?
|
| Taurine | 1 | 1970 | 92 | 0.020 |
Why?
|
| Cohort Studies | 4 | 2008 | 41795 | 0.020 |
Why?
|
| Oligosaccharides | 1 | 1992 | 406 | 0.020 |
Why?
|
| Mediodorsal Thalamic Nucleus | 1 | 2009 | 12 | 0.020 |
Why?
|
| Foot | 1 | 1973 | 577 | 0.020 |
Why?
|
| Abnormalities, Drug-Induced | 1 | 1992 | 340 | 0.020 |
Why?
|
| Bicuculline | 1 | 2009 | 96 | 0.020 |
Why?
|
| Carrier State | 1 | 1993 | 529 | 0.020 |
Why?
|
| GABA Antagonists | 1 | 2009 | 119 | 0.020 |
Why?
|
| Corpus Callosum | 3 | 2007 | 754 | 0.020 |
Why?
|
| Models, Biological | 1 | 2005 | 9493 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 2 | 2006 | 1705 | 0.020 |
Why?
|
| Sodium | 1 | 1974 | 1594 | 0.020 |
Why?
|
| Coenzyme A | 3 | 1973 | 39 | 0.020 |
Why?
|
| Precipitin Tests | 3 | 1974 | 816 | 0.020 |
Why?
|
| Glycosylation | 1 | 1992 | 1100 | 0.020 |
Why?
|
| Gangliosides | 1 | 2009 | 132 | 0.020 |
Why?
|
| Neural Tube Defects | 1 | 1991 | 255 | 0.020 |
Why?
|
| Thrombolytic Therapy | 1 | 1997 | 2050 | 0.020 |
Why?
|
| Child Behavior | 1 | 1974 | 865 | 0.020 |
Why?
|
| Hemodynamics | 1 | 2019 | 4199 | 0.020 |
Why?
|
| Biological Transport | 1 | 1993 | 2085 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2006 | 11918 | 0.020 |
Why?
|
| GAP-43 Protein | 1 | 2008 | 152 | 0.020 |
Why?
|
| Sodium Channel Blockers | 1 | 2009 | 173 | 0.020 |
Why?
|
| Body Composition | 1 | 1998 | 2461 | 0.020 |
Why?
|
| Tetrodotoxin | 1 | 2009 | 245 | 0.020 |
Why?
|
| Disease Progression | 3 | 2006 | 13646 | 0.020 |
Why?
|
| Survival Rate | 2 | 2006 | 12870 | 0.020 |
Why?
|
| Excitatory Amino Acid Transporter 1 | 1 | 2007 | 18 | 0.020 |
Why?
|
| Cerebellar Nuclei | 1 | 2007 | 54 | 0.020 |
Why?
|
| Adult | 8 | 2019 | 223640 | 0.020 |
Why?
|
| Ischemia | 1 | 1996 | 1900 | 0.020 |
Why?
|
| Congenital Abnormalities | 2 | 2007 | 708 | 0.020 |
Why?
|
| Bisbenzimidazole | 1 | 2006 | 13 | 0.020 |
Why?
|
| Species Specificity | 1 | 2011 | 2417 | 0.020 |
Why?
|
| Mice, Knockout | 3 | 2008 | 14481 | 0.020 |
Why?
|
| Risk | 1 | 2019 | 9636 | 0.020 |
Why?
|
| Aspartic Acid | 1 | 2009 | 577 | 0.020 |
Why?
|
| Patch-Clamp Techniques | 1 | 2009 | 927 | 0.020 |
Why?
|
| Epilepsy | 1 | 2002 | 3326 | 0.020 |
Why?
|
| Mice | 7 | 2008 | 82017 | 0.020 |
Why?
|
| Postmortem Changes | 1 | 2006 | 119 | 0.020 |
Why?
|
| Cobalt | 1 | 2006 | 148 | 0.020 |
Why?
|
| Estrogen Receptor beta | 1 | 2007 | 171 | 0.020 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2006 | 127 | 0.020 |
Why?
|
| Cattle | 1 | 1992 | 3826 | 0.020 |
Why?
|
| Hospitals, Pediatric | 1 | 2015 | 1876 | 0.020 |
Why?
|
| Membrane Potentials | 1 | 2009 | 1090 | 0.020 |
Why?
|
| Occipital Lobe | 2 | 2003 | 376 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 2 | 2006 | 6234 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2001 | 9379 | 0.020 |
Why?
|
| Ki-67 Antigen | 1 | 2008 | 628 | 0.020 |
Why?
|
| Isoenzymes | 1 | 1970 | 1684 | 0.020 |
Why?
|
| I-kappa B Kinase | 1 | 2006 | 250 | 0.020 |
Why?
|
| Antigens, Differentiation | 1 | 2008 | 921 | 0.020 |
Why?
|
| Haplorhini | 3 | 1970 | 524 | 0.020 |
Why?
|
| Hot Temperature | 1 | 1992 | 1440 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2011 | 2862 | 0.020 |
Why?
|
| Neuropeptides | 1 | 2011 | 950 | 0.020 |
Why?
|
| Fatty Acids | 1 | 1973 | 1815 | 0.010 |
Why?
|
| Insulin | 2 | 2003 | 6607 | 0.010 |
Why?
|
| Cause of Death | 1 | 2015 | 3728 | 0.010 |
Why?
|
| Apoptosis Inducing Factor | 1 | 2004 | 51 | 0.010 |
Why?
|
| Transforming Growth Factor alpha | 1 | 2004 | 135 | 0.010 |
Why?
|
| Lipoxygenase Inhibitors | 1 | 2004 | 93 | 0.010 |
Why?
|
| Blindness, Cortical | 1 | 2004 | 17 | 0.010 |
Why?
|
| Superoxides | 1 | 2005 | 389 | 0.010 |
Why?
|
| Receptors, Interferon | 1 | 2004 | 115 | 0.010 |
Why?
|
| Middle Aged | 8 | 2013 | 223491 | 0.010 |
Why?
|
| Subarachnoid Space | 1 | 2004 | 79 | 0.010 |
Why?
|
| Peroxides | 1 | 2004 | 76 | 0.010 |
Why?
|
| gamma-Glutamylcyclotransferase | 1 | 2003 | 11 | 0.010 |
Why?
|
| Energy Metabolism | 1 | 1995 | 2906 | 0.010 |
Why?
|
| Amino Acids | 1 | 1970 | 1716 | 0.010 |
Why?
|
| Swine, Miniature | 2 | 1996 | 965 | 0.010 |
Why?
|
| Linear Models | 2 | 2005 | 5878 | 0.010 |
Why?
|
| Biopsy | 1 | 2015 | 6808 | 0.010 |
Why?
|
| Cranial Sutures | 1 | 2004 | 99 | 0.010 |
Why?
|
| Erythroid Precursor Cells | 1 | 2004 | 212 | 0.010 |
Why?
|
| Oxidants | 1 | 2004 | 168 | 0.010 |
Why?
|
| Intracellular Space | 1 | 2004 | 199 | 0.010 |
Why?
|
| Benzodiazepines | 1 | 2009 | 1139 | 0.010 |
Why?
|
| Estrogen Receptor alpha | 1 | 2007 | 581 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2007 | 2299 | 0.010 |
Why?
|
| Obstetric Labor, Premature | 1 | 2004 | 273 | 0.010 |
Why?
|
| Hepatitis C | 1 | 1993 | 1593 | 0.010 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2008 | 1114 | 0.010 |
Why?
|
| Optic Neuropathy, Ischemic | 1 | 2004 | 87 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2006 | 1905 | 0.010 |
Why?
|
| Dominance, Cerebral | 1 | 2004 | 624 | 0.010 |
Why?
|
| Sex Distribution | 1 | 2007 | 2281 | 0.010 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2006 | 582 | 0.010 |
Why?
|
| Spinal Puncture | 1 | 2004 | 286 | 0.010 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2005 | 4076 | 0.010 |
Why?
|
| Risk Assessment | 2 | 2017 | 24318 | 0.010 |
Why?
|
| Interleukin-8 | 1 | 2004 | 705 | 0.010 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2008 | 1141 | 0.010 |
Why?
|
| Luminescent Proteins | 1 | 2004 | 839 | 0.010 |
Why?
|
| Adrenalectomy | 3 | 1972 | 348 | 0.010 |
Why?
|
| Kidney | 2 | 1996 | 7064 | 0.010 |
Why?
|
| Receptors, Estrogen | 1 | 2009 | 2247 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2011 | 2890 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 2006 | 1674 | 0.010 |
Why?
|
| Prevalence | 2 | 2008 | 15872 | 0.010 |
Why?
|
| Pressure | 1 | 2004 | 1172 | 0.010 |
Why?
|
| Injections, Intraperitoneal | 1 | 2000 | 413 | 0.010 |
Why?
|
| Centrifugation | 2 | 1970 | 122 | 0.010 |
Why?
|
| Movement Disorders | 1 | 2004 | 464 | 0.010 |
Why?
|
| Interpersonal Relations | 1 | 2007 | 1440 | 0.010 |
Why?
|
| Models, Immunological | 1 | 2002 | 518 | 0.010 |
Why?
|
| Metabolic Diseases | 1 | 2006 | 684 | 0.010 |
Why?
|
| Fetal Development | 1 | 2005 | 771 | 0.010 |
Why?
|
| Inflammation Mediators | 1 | 2008 | 1890 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2006 | 3813 | 0.010 |
Why?
|
| Memory | 1 | 2009 | 2210 | 0.010 |
Why?
|
| Pain | 1 | 1974 | 5103 | 0.010 |
Why?
|
| Interleukin-10 | 1 | 2004 | 1184 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 2006 | 2201 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 1992 | 17626 | 0.010 |
Why?
|
| Perfusion | 1 | 2004 | 1402 | 0.010 |
Why?
|
| Receptors, Immunologic | 1 | 2005 | 1416 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 2002 | 1755 | 0.010 |
Why?
|
| Subtraction Technique | 1 | 2002 | 519 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2004 | 2069 | 0.010 |
Why?
|
| Protein Transport | 1 | 2004 | 1958 | 0.010 |
Why?
|
| Hippocampus | 1 | 2011 | 3784 | 0.010 |
Why?
|
| Attention | 1 | 2009 | 2425 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 2 | 2007 | 22355 | 0.010 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2002 | 587 | 0.010 |
Why?
|
| Activities of Daily Living | 1 | 2007 | 2433 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 2002 | 1753 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2006 | 2489 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 2004 | 2002 | 0.010 |
Why?
|
| Drug Resistance | 1 | 2004 | 1595 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 2003 | 3055 | 0.010 |
Why?
|
| Atrophy | 1 | 2003 | 1648 | 0.010 |
Why?
|
| Injections, Intraventricular | 1 | 1997 | 227 | 0.010 |
Why?
|
| Heart Failure | 1 | 2002 | 11858 | 0.010 |
Why?
|
| Ischemic Attack, Transient | 1 | 2003 | 877 | 0.010 |
Why?
|
| Brain Mapping | 1 | 2012 | 6740 | 0.010 |
Why?
|
| Survivors | 1 | 2007 | 2382 | 0.010 |
Why?
|
| Visual Fields | 1 | 2004 | 1067 | 0.010 |
Why?
|
| Methionine | 2 | 1970 | 573 | 0.010 |
Why?
|
| Hypernatremia | 2 | 1974 | 78 | 0.010 |
Why?
|
| Subarachnoid Hemorrhage | 2 | 1975 | 1039 | 0.010 |
Why?
|
| Trans-Activators | 1 | 2006 | 2856 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2019 | 65379 | 0.010 |
Why?
|
| Kidney Cortex | 1 | 1996 | 168 | 0.010 |
Why?
|
| Pentetic Acid | 1 | 1996 | 209 | 0.010 |
Why?
|
| Kidney Medulla | 1 | 1996 | 169 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2002 | 1974 | 0.010 |
Why?
|
| Meglumine | 1 | 1996 | 144 | 0.010 |
Why?
|
| Kinetics | 2 | 1973 | 6333 | 0.010 |
Why?
|
| Substance-Related Disorders | 1 | 1992 | 4429 | 0.010 |
Why?
|
| Reperfusion | 1 | 1996 | 266 | 0.010 |
Why?
|
| Hematocrit | 1 | 1996 | 625 | 0.010 |
Why?
|
| Neuronal Plasticity | 1 | 2004 | 1448 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 2008 | 7145 | 0.010 |
Why?
|
| Cerebrospinal Fluid Proteins | 1 | 1975 | 71 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2006 | 8326 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2004 | 3230 | 0.010 |
Why?
|
| Angiography, Digital Subtraction | 1 | 1996 | 332 | 0.010 |
Why?
|
| Crying | 1 | 1974 | 37 | 0.010 |
Why?
|
| Electrophoresis, Disc | 1 | 1973 | 66 | 0.010 |
Why?
|
| Chromatography, DEAE-Cellulose | 1 | 1973 | 81 | 0.010 |
Why?
|
| Stimulation, Chemical | 1 | 1974 | 305 | 0.010 |
Why?
|
| Chromatography | 1 | 1973 | 189 | 0.010 |
Why?
|
| Streptozocin | 1 | 1974 | 190 | 0.010 |
Why?
|
| Blood Cell Count | 1 | 1975 | 402 | 0.010 |
Why?
|
| Esophageal and Gastric Varices | 1 | 1996 | 215 | 0.010 |
Why?
|
| Immunodiffusion | 1 | 1973 | 141 | 0.010 |
Why?
|
| Euglena gracilis | 1 | 1973 | 3 | 0.010 |
Why?
|
| Starvation | 1 | 1973 | 141 | 0.010 |
Why?
|
| Osmolar Concentration | 1 | 1974 | 657 | 0.010 |
Why?
|
| Meningitis | 1 | 1975 | 219 | 0.010 |
Why?
|
| Animal Feed | 1 | 1973 | 108 | 0.010 |
Why?
|
| Body Weight | 1 | 2004 | 4629 | 0.010 |
Why?
|
| Weaning | 1 | 1973 | 103 | 0.010 |
Why?
|
| Acetyl-CoA Carboxylase | 1 | 1973 | 72 | 0.010 |
Why?
|
| Gadolinium DTPA | 1 | 1996 | 823 | 0.010 |
Why?
|
| Deficiency Diseases | 1 | 1973 | 74 | 0.010 |
Why?
|
| Phenobarbital | 1 | 1973 | 192 | 0.010 |
Why?
|
| Comorbidity | 1 | 2007 | 10588 | 0.010 |
Why?
|
| Carbon Radioisotopes | 1 | 1973 | 567 | 0.010 |
Why?
|
| Organometallic Compounds | 1 | 1996 | 648 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 1995 | 15881 | 0.010 |
Why?
|
| Methimazole | 1 | 1972 | 41 | 0.010 |
Why?
|
| Malonates | 1 | 1972 | 43 | 0.010 |
Why?
|
| Cystathionine | 1 | 1972 | 6 | 0.010 |
Why?
|
| Young Adult | 1 | 2019 | 60049 | 0.010 |
Why?
|
| Cell Migration Inhibition | 1 | 1972 | 97 | 0.010 |
Why?
|
| Mass Screening | 1 | 2008 | 5451 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2007 | 12805 | 0.010 |
Why?
|
| Hepatomegaly | 1 | 1972 | 84 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2008 | 10478 | 0.010 |
Why?
|
| Hypocalcemia | 1 | 1973 | 203 | 0.010 |
Why?
|
| Birth Injuries | 1 | 1973 | 151 | 0.010 |
Why?
|
| Yeasts | 1 | 1973 | 279 | 0.010 |
Why?
|
| Biotin | 1 | 1973 | 256 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2006 | 5800 | 0.010 |
Why?
|
| Histiocytes | 1 | 1972 | 97 | 0.010 |
Why?
|
| Allosteric Regulation | 1 | 1973 | 423 | 0.010 |
Why?
|
| Mycobacterium | 1 | 1973 | 252 | 0.010 |
Why?
|
| Mammary Glands, Animal | 1 | 1973 | 273 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 1973 | 1379 | 0.010 |
Why?
|
| NADP | 1 | 1972 | 230 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1995 | 2475 | 0.010 |
Why?
|
| Lactation | 1 | 1973 | 397 | 0.010 |
Why?
|
| Facial Expression | 1 | 1974 | 515 | 0.010 |
Why?
|
| Electrophoresis | 1 | 1970 | 226 | 0.010 |
Why?
|
| Immunoassay | 1 | 1974 | 745 | 0.010 |
Why?
|
| Age of Onset | 1 | 1997 | 3345 | 0.010 |
Why?
|
| Estrogens, Conjugated (USP) | 1 | 1972 | 277 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 1973 | 1435 | 0.010 |
Why?
|
| Purkinje Cells | 1 | 1972 | 228 | 0.010 |
Why?
|
| Carrier Proteins | 2 | 1973 | 4936 | 0.010 |
Why?
|
| Hypoglycemic Agents | 1 | 2003 | 3108 | 0.010 |
Why?
|
| Sensation | 1 | 1972 | 337 | 0.010 |
Why?
|
| Optic Chiasm | 1 | 1970 | 91 | 0.010 |
Why?
|
| Drug Combinations | 1 | 1996 | 2079 | 0.010 |
Why?
|
| Glucagon | 1 | 1972 | 534 | 0.010 |
Why?
|
| Growth Hormone | 1 | 1972 | 573 | 0.010 |
Why?
|
| Multienzyme Complexes | 1 | 1973 | 665 | 0.010 |
Why?
|
| Macrophages | 1 | 2004 | 5796 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 1970 | 699 | 0.010 |
Why?
|
| Carbon Isotopes | 1 | 1970 | 458 | 0.010 |
Why?
|
| Vision, Ocular | 1 | 1972 | 458 | 0.000 |
Why?
|
| Lysine | 1 | 1973 | 988 | 0.000 |
Why?
|
| Organ Specificity | 1 | 1973 | 1967 | 0.000 |
Why?
|
| Thyroxine | 1 | 1972 | 665 | 0.000 |
Why?
|
| Spectrum Analysis | 1 | 1970 | 449 | 0.000 |
Why?
|
| Aging | 2 | 2000 | 8764 | 0.000 |
Why?
|
| Hearing | 1 | 1972 | 502 | 0.000 |
Why?
|
| Neoplasm Invasiveness | 1 | 1996 | 3633 | 0.000 |
Why?
|
| Movement | 1 | 1974 | 1490 | 0.000 |
Why?
|
| Liver Diseases | 1 | 1996 | 1304 | 0.000 |
Why?
|
| Methylation | 1 | 1970 | 1076 | 0.000 |
Why?
|
| Pituitary Gland | 1 | 1970 | 634 | 0.000 |
Why?
|
| Polysaccharides | 1 | 1973 | 1024 | 0.000 |
Why?
|
| Growth Disorders | 1 | 1972 | 635 | 0.000 |
Why?
|
| Fasting | 1 | 1973 | 1610 | 0.000 |
Why?
|
| Rabbits | 1 | 1973 | 4781 | 0.000 |
Why?
|
| Brain Chemistry | 1 | 1970 | 962 | 0.000 |
Why?
|
| Aged | 3 | 2007 | 171562 | 0.000 |
Why?
|
| Hypoglycemia | 1 | 1973 | 894 | 0.000 |
Why?
|
| Staining and Labeling | 1 | 1970 | 1081 | 0.000 |
Why?
|
| Phagocytosis | 1 | 1972 | 1530 | 0.000 |
Why?
|
| Cell Nucleus | 1 | 1975 | 2886 | 0.000 |
Why?
|
| Reproducibility of Results | 1 | 2004 | 20224 | 0.000 |
Why?
|
| Syndrome | 1 | 1972 | 3275 | 0.000 |
Why?
|
| Dietary Fats | 1 | 1973 | 2003 | 0.000 |
Why?
|
| Binding Sites | 1 | 1973 | 6017 | 0.000 |
Why?
|
| Algorithms | 1 | 2005 | 14154 | 0.000 |
Why?
|
| Pilot Projects | 1 | 1997 | 8731 | 0.000 |
Why?
|
| Contrast Media | 1 | 1996 | 5336 | 0.000 |
Why?
|
| Thrombosis | 1 | 1996 | 2955 | 0.000 |
Why?
|
| Protein Binding | 1 | 1973 | 9343 | 0.000 |
Why?
|
| Intensive Care Units | 1 | 1975 | 3801 | 0.000 |
Why?
|
| Burns | 1 | 1972 | 1893 | 0.000 |
Why?
|
| Escherichia coli | 1 | 1973 | 4211 | 0.000 |
Why?
|
| Adolescent | 1 | 2007 | 89184 | 0.000 |
Why?
|
| Diabetes Mellitus | 1 | 1974 | 5891 | 0.000 |
Why?
|
| Diet | 1 | 1972 | 8090 | 0.000 |
Why?
|
| Wound Infection | 1 | 1972 | 243 | 0.000 |
Why?
|
| Hallucinations | 1 | 1972 | 375 | 0.000 |
Why?
|
| Sulfur | 1 | 1968 | 160 | 0.000 |
Why?
|
| Personality Disorders | 1 | 1972 | 729 | 0.000 |
Why?
|
| Adrenal Glands | 1 | 1968 | 557 | 0.000 |
Why?
|
| Intestine, Small | 1 | 1968 | 1218 | 0.000 |
Why?
|
| Estrogens | 1 | 1968 | 1534 | 0.000 |
Why?
|
| Delirium | 1 | 1972 | 1695 | 0.000 |
Why?
|
| Adrenal Cortex Hormones | 1 | 1968 | 1890 | 0.000 |
Why?
|